Search research articles
Contact Us
Filters
Showing results (41-50 of 130) with videos related to
Page
of 13
Sort By:
British Journal of Pharmacology
|
January 1, 1989
The effects of acute and chronic desipramine on the thermogenic and hypoactivity responses to alpha 2-agonists in reserpinized and normal mice
D J Bill, I E Hughes, R J Stephens
British Journal of Cancer
|
December 1, 1985
Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma
D J Girling, H Stott, R J Stephens, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
April 1, 1997
Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?
R J Stephens, P Hopwood, D J Girling, et al.
British Journal of Cancer
|
August 1, 1976
5-year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus
H Stott, R J Stephens, W Fox, et al.
Experimental and Molecular Pathology
|
August 1, 1982
Postnatal tolerance to NO2 toxicity
R J Stephens, C Tallent, C Hart, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 1, 1997
Sample sizes for randomized trials measuring quality of life in cancer patients
S A Julious, S George, D Machin, et al.
Analytical Biochemistry
|
November 1, 1992
Quantitative determination of hydroxy fatty acids as an indicator of in vivo lipid peroxidation: oxidation products of arachidonic and docosapentaenoic acids in rat liver after exposure to carbon tetrachloride
D W Thomas, F J van Kuijk, R J Stephens
British Journal of Cancer
|
December 1, 1993
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party
N M Bleehen, D J Girling, D Machin, et al.
Experimental and Molecular Pathology
|
February 1, 1974
Alveolar type 1 cell response to exposure to 0.5 PPM O3 for short periods
R J Stephens, M F Sloan, M J Evans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2011
Chemotherapy dose reductions in obese patients with colorectal cancer
P Chambers, S H Daniels, L C Thompson, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 130) with videos related to
Sort By:
Page
of 13
British Journal of Pharmacology
|
January 1, 1989
The effects of acute and chronic desipramine on the thermogenic and hypoactivity responses to alpha 2-agonists in reserpinized and normal mice
D J Bill, I E Hughes, R J Stephens
British Journal of Cancer
|
December 1, 1985
Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma
D J Girling, H Stott, R J Stephens, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
April 1, 1997
Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?
R J Stephens, P Hopwood, D J Girling, et al.
British Journal of Cancer
|
August 1, 1976
5-year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus
H Stott, R J Stephens, W Fox, et al.
Experimental and Molecular Pathology
|
August 1, 1982
Postnatal tolerance to NO2 toxicity
R J Stephens, C Tallent, C Hart, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 1, 1997
Sample sizes for randomized trials measuring quality of life in cancer patients
S A Julious, S George, D Machin, et al.
Analytical Biochemistry
|
November 1, 1992
Quantitative determination of hydroxy fatty acids as an indicator of in vivo lipid peroxidation: oxidation products of arachidonic and docosapentaenoic acids in rat liver after exposure to carbon tetrachloride
D W Thomas, F J van Kuijk, R J Stephens
British Journal of Cancer
|
December 1, 1993
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party
N M Bleehen, D J Girling, D Machin, et al.
Experimental and Molecular Pathology
|
February 1, 1974
Alveolar type 1 cell response to exposure to 0.5 PPM O3 for short periods
R J Stephens, M F Sloan, M J Evans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2011
Chemotherapy dose reductions in obese patients with colorectal cancer
P Chambers, S H Daniels, L C Thompson, et al.
Page
of 13